Literature DB >> 19165543

Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis.

T M Earl1, I B Nicoud, J M Pierce, J P Wright, N E Majoras, J E Rubin, K P Pierre, D L Gorden, R S Chari.   

Abstract

BACKGROUND: The relationship between obesity and cancer has become of particular interest due to the rapidly growing prevalence of overweight individuals. Obesity predisposes individuals to the development of hepatic steatosis and is an independent risk factor for several neoplasms. Toll-like receptor 4 (TLR4) is the innate receptor for endotoxin, and steatotic livers are known to be sensitive to endotoxin. TLR4 signaling has been shown to have proneoplastic effects in vitro due to its effect on immune surveillance. Thus far, studies have predominantly focused on the effect of tumor-cell-derived TLR4 without regard to host TLR4 signaling.
RESULTS: In the present study we show that steatotic livers have increased expression of TLR4. Obese animals developed higher metastatic tumor burden in the liver than lean controls regardless of the presence or absence of intact host TLR4. After silencing TLR4 expression using RNAi in the mouse colon cancer cell line MC38, there was a significant decrease in metastatic tumor burden within the liver of obese animals.
CONCLUSIONS: These findings demonstrate that steatotic livers have increased susceptibility to metastatic tumor growth and that silencing tumor cell TLR4 reduces metastatic tumor burden in steatotic liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165543     DOI: 10.1245/s10434-009-0325-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  22 in total

1.  S100A8/A9 activate key genes and pathways in colon tumor progression.

Authors:  Mie Ichikawa; Roy Williams; Ling Wang; Thomas Vogl; Geetha Srikrishna
Journal:  Mol Cancer Res       Date:  2011-01-12       Impact factor: 5.852

2.  Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.

Authors:  Ming-Heng Wu; Wen-Lung Ma; Cheng-Lung Hsu; Yuh-Ling Chen; Jing-Hsiung James Ou; Charlotte Kathryn Ryan; Yao-Ching Hung; Shuyuan Yeh; Chawnshang Chang
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

3.  Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

Authors:  Lisa Volk-Draper; Kelly Hall; Caitlin Griggs; Sandeep Rajput; Pascaline Kohio; David DeNardo; Sophia Ran
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

4.  Hyaluronic Acid Binding to TLR4 Promotes Proliferation and Blocks Apoptosis in Colon Cancer.

Authors:  Sarbjeet Makkar; Terrence E Riehl; Baosheng Chen; Yan Yan; David M Alvarado; Matthew A Ciorba; William F Stenson
Journal:  Mol Cancer Ther       Date:  2019-09-04       Impact factor: 6.261

5.  NOD-like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD.

Authors:  Koichiro Ohashi; Zhijun Wang; Yoon Mee Yang; Sandrine Billet; Wei Tu; Michael Pimienta; Suzanne L Cassel; Stephen J Pandol; Shelly C Lu; Fayyaz S Sutterwala; Neil Bhowmick; Ekihiro Seki
Journal:  Hepatology       Date:  2019-05-23       Impact factor: 17.425

6.  Neutrophil Extracellular Traps Drive Mitochondrial Homeostasis in Tumors to Augment Growth.

Authors:  Hamza O Yazdani; Eva Roy; Alexander J Comerci; Dirk J van der Windt; Hongji Zhang; Hai Huang; Patricia Loughran; Sruti Shiva; David A Geller; David L Bartlett; Allan Tsung; Tai Sheng; Richard L Simmons; Samer Tohme
Journal:  Cancer Res       Date:  2019-09-13       Impact factor: 12.701

7.  Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis.

Authors:  Ekihiro Seki; Eekjoong Park; Jiro Fujimoto
Journal:  Hepatol Res       Date:  2011-06-22       Impact factor: 4.288

8.  Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells.

Authors:  Hung Q Doan; Kanika A Bowen; Lindsey A Jackson; B Mark Evers
Journal:  Anticancer Res       Date:  2009-07       Impact factor: 2.480

9.  High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.

Authors:  E L Wang; Z R Qian; M Nakasono; T Tanahashi; K Yoshimoto; Y Bando; E Kudo; M Shimada; T Sano
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer.

Authors:  Koji Murono; Joji Kitayama; Nelson H Tsuno; Hiroaki Nozawa; Kazushige Kawai; Eiji Sunami; Masaaki Akahane; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2013-02-08       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.